v3.26.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

Note 10 – Stock-Based Compensation

 

A summary of the Company’s Share Incentive Plans are as follows:

 

2007 Share Incentive Plan

 

On December 12, 2007, shareholders approved the Company’s 2007 Share Incentive Plan (“2017 Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2017 Incentive Plan through December 12, 2017. The Plan expired in December 2017. As of December 31, 2025, there were 120,000 options outstanding under this plan.

 

2016 Share Incentive Plan

 

On December 9, 2016, shareholders approved the Company’s 2016 Share Incentive Plan (“2016 Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2016 Incentive Plan through December 9, 2026. As of December 31, 2025, there were 420,375 options outstanding under this plan.

 

2022 Share Incentive Plan

 

On July 14, 2022, shareholders approved the Company’s 2022 Share Incentive Plan (“2022 Incentive Plan”), in connection therewith, 515,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2022 Incentive Plan through July 14, 2032. As of December 31, 2025, there were 263,500 options outstanding under this plan.

 

Under the 2016 and 2022 Share Incentive Plans, the purchase price of the common stock under each option plan shall be determined by the Committee, provided, however, that such purchase price shall not be less than the fair market value of the shares on the date such option is granted. The stock options generally expire seven to ten years after the date of grant.

 

As of December 31, 2025, there were 48,698 shares available for grant under the 2016 Equity Incentive Plan and 98,180 shares available for grant under the 2022 Equity Incentive Plan.

 

The Company recorded stock-based compensation of $0.9 million and $1.1 million for the years ended December 31, 2025 and 2024, respectively, that were included in the following line items in our Consolidated Statements of Operations (in thousands):

 

   2025   2024 
         
Cost of revenue  $99   $152 
Research and development   157    188 
Selling   73    107 
General and administrative   613    616 
           
Total stock-based compensation expense  $942   $1,063 

 

Stock-based compensation expense in both years included approximately $0.2 million related to restricted stock awards pursuant to the Director Compensation plan discussed below. The Company recognizes forfeitures of stock awards as they occur.

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2025 and 2024

 

Note 10 – Stock-Based Compensation (continued)

 

For the year ended December 31, 2024, the Company granted 5,000 stock options, vesting 25% per year over four years, with a ten-year life. The Company determined the fair value of stock options granted based upon weighted average assumptions as provided below.

 

Stock price  $4.75 
Exercise price  $4.75 
Dividend yield   0%
Expected volatility   77%
Risk-free interest rate   4.12%
Expected life (in years)   6.00 

 

The expected life is the number of years the Company estimates that the awards will be outstanding based on the simplified method that considers the vesting period and contractual period of the option. The expected volatility is measured using historical daily price changes of the Company’s common stock over the respective expected term. The Company has 803,875 outstanding stock options under the three plans at December 31, 2025.

 

The following table summarizes stock options awards for the years ended December 31, 2025 and 2024:

 

       Weighted 
   Awards
(in Shares)
   Average
Exercise Price
 
Outstanding at December 31, 2023   846,875   $8.20 
Granted   5,000    4.75 
Expired / cancelled   (28,750)   7.94 
Exercised   -    - 
Outstanding at December 31, 2024   823,125    8.20 
Granted   -    - 
Expired / cancelled   (19,250)   11.09 
Exercised   -    - 
Outstanding at December 31, 2025   803,875    8.17 

 

At December 31, 2025 and 2024, stock options to purchase 645,375 and 485,000, respectively, shares of common stock were exercisable.

 

The following table summarizes information about the outstanding and exercisable options at December 31, 2025:

 

   Options Outstanding   Options Exercisable 
       Weighted   Weighted           Weighted     
       Average   Average           Average     
Exercise  Number   Remaining   Exercise   Intrinsic   Number   Exercise   Intrinsic 
Price Range  Outstanding   Contractual   Price   Value   Exercisable   Price   Value 
$ 4.00-7.00    440,875    6.0   $4.54   $-    392,625   $4.48   $- 
$ 7.01-10.00    20,000    2.3   $8.07   $      -    20,000   $8.07   $- 
$ 10.01-13.00    120,000    1.2   $10.52   $-    120,000   $10.52   $- 
$ 13.01-16.00    223,000    7.2   $14.11   $-    112,750   $14.11   $- 

 

 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2025 and 2024

 

Note 10 – Stock-Based Compensation (continued)

 

As of December 31, 2025, there was $0.7 million of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 1.2 years.

 

Restricted Stock Awards

 

Pursuant to the Director Compensation plan approved on October 11, 2021, each of the five independent directors is entitled to compensation for an annual equity retainer in the amount of $40,000 per director, to be automatically granted on the date of the Company’s annual meeting of shareholders.

 

The following table summarizes restricted stock awards for the years ended December 31, 2025 and 2024:

 

       Weighted 
       Average Grant 
   Shares of   Date Fair 
   Restricted Stock   Value 
Unvested outstanding at January 1, 2024   17,133   $6.53 
Granted   57,327    3.55 
Vested   (46,210)   4.63 
Forfeited or cancelled   -    - 
Unvested outstanding at December 31, 2024   28,250    3.54 
           
Granted   55,500    3.61 
Vested   (56,000)   3.57 
Forfeited or cancelled   -    - 
Unvested outstanding at December 31, 2025   27,750   $3.61 

 

The fair value of the restricted stock awards is recorded as stock-based compensation expense over the one-year vesting period and totaled $0.2 million for both years ending December 31, 2025 and 2024, respectively.